When Lorraine Kelly Donnelly felt a cramp in her left hand at the start of 2025, she didn't think anything of it. But when a week later the pain was still there, she made an appointment to see her GP.
The funds raised through Visionaries of the Year are used for research to advance lifesaving therapies like immunotherapy, genomics and personalized medicine, which are saving lives today.
Some 1 million patients in the U.S. live with a type of heart disease called heart failure with preserved ejection fraction, or HFpEF, caused by a stiffening of a chamber of the heart that makes it much more challenging to distribute blood throughout the body. The condition has few approved therapies and high mortality rates.
When mitochondria are exposed to tissue or blood, they lose the electrical gradient across their outer membrane. Mitochondria that lack such a gradient are recognized by a cell's internal machinery as damaged and quickly destroyed. The vast majority of previous studies involved injecting 'naked' mitochondria directly into the bloodstream or tissue sites, but the approach isn't very efficient, so researchers often have to use 'ridiculous' doses of mitochondria.
The revamped outpatient space folds in more infusion stations, extra exam rooms and added specialty clinics, which officials and neighborhood advocates hope will shrink travel times and long waits for patients across southern Brooklyn. The center now stretches South Brooklyn Health's outpatient cancer footprint with additional infusion bays, more exam rooms and extra clinical staff.
The surgery was long and grueling - almost 12 hours - and my recovery was tough. I couldn't lift my baby for weeks. My husband served as a caregiver for both me and our son, while my mom and sisters rotated shifts to help. I hated feeling like a visitor in my own life, but slowly my strength began to return. It took me about a year to fully recover and start to feel like myself again.
As the Magerstadt Professor of Cardiovascular Epidemiology, Khan studies the epidemiology of risk for heart failure. Using population-based cohorts and large electronic health record data analyses, she performs mechanistic studies that may enhance risk prediction and identify novel therapeutic agents for the prevention and treatment of cardiovascular disease. Khan and her team have developed a tool to predict risk and prevent cardiovascular disease such as heart failure, stroke, arrhythmia, coronary artery disease and many other conditions.
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
As you age, inactivity can lead to a variety of cardiovascular problems, one of which involves stiffening of the heart's left ventricle. That's the chamber responsible for pumping oxygen-rich blood to the rest of the body. According to Dr. Benjamin Levine , Director of the Institute and Professor of Internal Medicine at University of Texas Southwestern (UTSW), "When the muscle stiffens, you get high pressure and the heart chamber doesn't fill as well with blood."
It may have started earlier, but it came to a head in the middle of the night in the middle of London in the middle of last November, when former Tour de France green jersey winner Sam Bennett woke up with a weird sensation in his chest. His heart rate was unusually high for somebody who had been asleep a few moments earlier, let alone for a professional athlete with a resting heart rate in the low 40s.
New findings on cancer survival rates offer hope for the more than 2 million Americans diagnosed each year. Seven out of 10 Americans diagnosed with cancer now survive five years or more, according to the American Cancer Society, a 7 percent increase since the mid-1990s, when the rate stood at 63 percent. The survival rate data - from patients diagnosed with cancer between 2015 and 2021 - showed, significantly, that those with high-mortality cancers and advanced diagnoses had the largest gains.
He has been living with atrial fibrillation (AF), a common heart rhythm problem, affecting 1.4m people in the UK, that can cause your heart to beat irregularly and often too fast. "It's very debilitating. On my worst day I feel very tired, my heart rate increases rapidly - I could walk for 2 or 3 miles and be okay, I could walk for 100 yards and it would hit me."
Mucopolysaccharidosis type II (MPS II), or Hunter syndrome, is a rare genetic disorder primarily affecting boys, caused by a deficiency in the enzyme needed to break down sugar molecules. This harmful buildup in cells and tissues impacts multiple body systems, causing frequent infections, organ enlargement and developmental disabilities. Management involves supportive care and enzyme replacement therapy, as there is currently no cure,
I'm certainly confident that we're going to have a breakthrough within my career, and I have a good 10 to 15 years left. While antiretroviral (ARV) therapies are extending lives and keeping HIV at bay, and PrEP has the potential to effectively halt transmission of the virus, a cure has remained elusive. That's because the HIV virus itself is elusive, both co-opting the immune system and hiding from it.
Male, 56 years old, resident of CastillaLa Mancha He had already undergone a heart transplant at the 12 de Octubre Hospital in August 2017. After an initially good evolution during the first years, his new heart began to deteriorate progressively and did not respond to any of the therapeutic measures used. He was placed on the waiting list for a retransplant in August 2024.
But these studies typically require large numbers of patients, huge amounts of data, and thorough follow-ups, none of which comes easy or free. The upshot is fewer investigations into scenarios that are clinically important but unlikely to yield a profit for the firms funding them. Accordingly, researchers have been developing an option that uses real-world data from insurers to save patients from falling through the cracks.
A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, according to results from a major U.S. clinical trial published in JAMA. Peripheral artery disease (PAD) is a serious condition that affects blood flow to the legs, making walking painful and difficult. It impacts approximately 12 million adults in the U.S. and is linked to higher risks of heart attack and stroke.
A study led by Stanford Medicine researchers has found that an injection blocking a protein linked to aging can reverse the natural loss of knee cartilage in older mice. The same treatment also stopped arthritis from developing after knee injuries that resemble ACL tears, which are common among athletes and recreational exercisers. Researchers note that an oral version of the treatment is already being tested in clinical trials aimed at treating age-related muscle weakness.
A 33-year-old man survived for 48 hours without his lungs, after a medical team replaced the organs with an external artificial-lung system that it developed to keep him alive until he could receive a double lung transplant. There have been cases in which people have had their lungs removed and been connected to an external device to maintain oxygen levels.
Northwestern University has launched the Simpson Querrey Brain Health Institute (SQ-Brain), made possible by nearly $25 million in philanthropic funding from university trustee Kimberly K. Querrey ('22, '23 P). SQ-Brain envisions a future where our brains last as long as our bodies a world where brain health is continuously measurable, modifiable and monitorable across the lifespan, and where prevention of cognitive decline and brain injury is anchored in neurovascular biology and precision medicine.
A Colorado endocrinologist helped spark a quiet revolution in weight care by changing how primary care clinics talk about - and treat - obesity. Instead of vague advice to "eat less and exercise more," a new system called PATHWEIGH gave patients a clear, judgment-free path to real medical support for weight management.